Recently, the National Immunization Plan (NIP) in Italy has highlighted the importance of immunization practices also for adults, including vaccinations against influenza, Pneumococcus (PNO) and HZ. In response to the NIP, the Calabria region decided to offer HZ vaccination to the two cohorts of 65- and 70-year-old subjects. We at the Reggio Calabria Local Health Services, concentrated our efforts on addressing all the above-mentioned shortcomings and, as a first measure, we addressed the convenience problem by scheduling the HZ vaccine administration during the same visit as the pneumococcal vaccination (PCV13 vaccine). The adhesion rates were satisfactory in both cohorts—such high levels of vaccine coverage for HZ and PCV13 had never been reached before in our region and are still among the highest in Italy. However, the main result was undoubtedly the significantly high rate of PCV13 and HZ vaccine co-administration without safety problems.
This is a preview of subscription content, log in to check access.
Compliance with ethical standards
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Statement of human and animal rights
All procedures performed in this study were in accordance with the ethical standards of the institutional research committee (Ethical approval by the Ethical Committee of the Department of Medicine, Helsinki University Central Hospital) and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
Miller E, Marshall R, Vurdien J (1993) Epidemiology, outcome and control of varicella-zoster infection. Rev Med Microbiol 4:222–230CrossRefGoogle Scholar
Kawai K, Gebremeskel BG, Acosta CJ (2014) Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open 4:e004833CrossRefGoogle Scholar
Alicino C, Trucchi C, Paganino C et al (2017) Incidence of herpes zoster and post-herpetic neuralgia in Italy: Results from a 3-years population-based study. Hum Vaccines Immunother 13:399–404CrossRefGoogle Scholar
Bricout H, Perinetti E, Marchettini P et al (2014) Burden of herpes zoster-associated chronic pain in Italian patients aged 50 years and over (2009–2010): a GP-based prospective cohort study. BMC Infect Dis 14:63CrossRefGoogle Scholar
Oxman MN, Levin MJ, Johnson GR et al (2005) A vaccine to prevent Herpes Zoster and Post-Herpetic Neuralgias in older adults. N Engl J Med 352:2271–2284CrossRefGoogle Scholar
Schmader KE, Levin MJ, Gnann JW et al (2012) Efficacy, safety and tolerability of Herpes Zoster vaccine in persons aged 50–59 years. Clin Infect Dis 54:922–928CrossRefGoogle Scholar
Amirthalingam G, Andrews N, Kell P et al (2017) Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study. Lancet Public Health 2018 3:e82–e90CrossRefGoogle Scholar